Biomol April 2026: activity review, scientific congresses and business positioning
April was a highly active period for Biomol. In this Biomol April 2026 activity review, we look back at the main corporate, scientific and business milestones that strengthened the company’s presence in the biomedical sector.
On one hand, Biomol took part in leading national congresses. On the other hand, the company reinforced its relationship with professionals working in research, diagnostics and precision medicine.
In addition, Biomol gained visibility as a Seville-based company specialised in solutions for molecular biology, molecular diagnostics and biomedical research.
All these actions reflect a clear idea: Biomol continues to grow without losing its essence. Proximity, responsiveness and direct involvement remain at the core of the company’s way of working.
One of the most relevant milestones was the interview published in Diario de Sevilla. This feature allowed Biomol to explain who we are, how we have evolved and where we are heading.
Biomol in Diario de Sevilla: an interview to share our evolution
One of the most important highlights of Biomol April 2026 was the interview published in Diario de Sevilla.
The interview featured Ángel Alcalde, president and founder of Biomol, and Rafael Estévez, CEO of the company.
Under the headline “What sets Biomol apart is proximity, responsiveness and direct involvement in projects”, the interview highlighted some of the values that best define our journey.
These include customer proximity, technical knowledge, adaptability and real commitment to every project.
In addition, the publication provided an opportunity to explain Biomol’s evolution. The company was founded in Seville as a business specialised in molecular and cellular biology. Today, Biomol has a national presence, a renewed strategy and a clear commitment to personalised medicine, biotechnology and the development of its own solutions.
The interview also highlighted one of our main strengths. Biomol does not act only as a supplier. Instead, the company supports researchers, hospitals, laboratories and reference centres as a technical partner in the development of their projects.
Therefore, this feature contributed to strengthening Biomol’s visibility within the Andalusian business and scientific ecosystem. It also projected an image aligned with the company’s new stage of growth, specialisation and innovation.
Biomol and Cámara de Comercio: business momentum and innovation
Biomol’s relationship with Cámara de Comercio has also been key to the company’s business positioning.
This space connects innovation, business and economic development. It also reinforces Biomol’s role as a biotechnology company with a clear growth mindset.
This connection helps position Biomol as a Seville-based company with national projection. It also shows the company’s ability to bring value to the biomedical ecosystem from Andalusia.
Being present in this environment increases the visibility of scientific and technology-based companies within the business landscape. It also underlines the importance of promoting projects based on knowledge, applied research and transfer to the healthcare sector.
For Biomol, being part of these initiatives means strengthening its institutional and business collaboration network. At the same time, it opens new opportunities to connect with organisations, professionals and entities committed to innovation.
Biomol at national scientific congresses
In addition to corporate visibility, Biomol’s presence at scientific congresses was another major activity pillar.
The team took part in leading national events. As a result, Biomol maintained direct contact with professionals, researchers and specialists from different biomedical areas.
Biomol was present at:
- 4th National Multidisciplinary Meeting on Innovation in Cancer, in Málaga.
- 36th National Congress of the Spanish Diabetes Society, in Seville.
- 5th Interdisciplinary Congress on Human Genetics, in Granada.
These events reflect Biomol’s commitment to strategic areas such as oncology, human genetics, molecular biology, molecular diagnostics and personalised medicine.
However, these congresses are not just a sequence of events. They are spaces to listen to the sector, identify new needs and strengthen professional relationships.
They are also an opportunity to bring valuable solutions closer to those working in research, diagnostics and healthcare.
Biomol in motion: cross-functional teamwork
The activity of Biomol April 2026 also reflected the company’s cross-functional involvement.
Several areas came together: scientific presence, commercial activity, business development and corporate communication.
The FAS, Sales, Expansion and Marketing teams worked in coordination to strengthen Biomol’s presence at congresses, professional meetings and business spaces.
This coordination follows a shared approach: staying close to the sector, listening to its needs and building valuable relationships.
Moreover, this way of working is directly connected to Biomol’s essence. Proximity, technical specialisation, responsiveness and commitment to every project remain key pillars of the company.
Biomol continues to move forward in research, diagnostics and precision medicine
Every congress, every meeting and every communication action contributes to Biomol’s positioning.
This Biomol April 2026 activity review reflects a stage of consolidation, connection and growth. It also shows strong activity in both the scientific and business environments.
Even so, this pace does not make us lose our essence. Biomol remains close to those who drive innovation in research, diagnostics and healthcare.
We continue to move forward, grow and bring value through science, technology and specialised support.
